Literature DB >> 10722631

Intracellular trafficking and killing of Streptococcus pneumoniae by human alveolar macrophages are influenced by opsonins.

S B Gordon1, G R Irving, R A Lawson, M E Lee, R C Read.   

Abstract

Human alveolar macrophages (HAM) are the major resident phagocytic cells of the gas-exchanging areas of the lung. Following contact with macrophages, bacteria enter phagosomes, which gradually acquire the characteristics of terminal phagolysosomes, with incorporation of lysosome-associated membrane protein (LAMP). We measured the binding of type 1 Streptococcus pneumoniae to the surface of HAM and then measured subsequent internalization and phagosomal incorporation of LAMP-1 under various opsonic conditions. Opsonization with serum containing immunoglobulin resulted in significantly greater binding of pneumococci to HAM compared with opsonization with immunoglobulin G (IgG)-depleted serum containing complement, which in turn resulted in marginally increased binding over that observed in the absence of opsonization. Internalization of opsonized S. pneumoniae gradually increased to a maximum of 20% of bound bacteria by 120 min of warm incubation, with 20% of internalized pneumococci being localized within LAMP-containing compartments by 80 min. Internalization of opsonized S. pneumoniae by HAM correlated with a reduction of bacterial viability. When inocula were adjusted so that pneumococcal binding under different conditions was equalized, subsequent internalization, trafficking to LAMP-containing compartments, and reduction of bacterial viability were less efficient in the absence of opsonization than that observed following opsonization with adsorbed or IgG-replete adsorbed serum. Once bound to the surface of HAM, pneumococci opsonized with adsorbed serum with or without IgG were internalized, processed, and killed equally well. In conclusion, binding, intracellular trafficking, and killing of S. pneumoniae by HAM are each significantly increased by opsonization with serum containing immunogloblin and/or complement.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722631      PMCID: PMC97415          DOI: 10.1128/IAI.68.4.2286-2293.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases.

Authors:  E Caron; A Hall
Journal:  Science       Date:  1998-11-27       Impact factor: 47.728

2.  Phagocytosis requires repeated triggering of macrophage phagocytic receptors during particle ingestion.

Authors:  D R Shaw; F M Griffin
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

3.  A simple method for the determination of complement receptor-bearing mononuclear cells.

Authors:  J A Gelfand; A S Fauci; I Green; M M Frank
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

4.  Production of opsonins that facilitate phagocytosis of Streptococcus pneumoniae by human alveolar macrophages or neutrophils after vaccination with pneumococcal polysaccharide.

Authors:  D G Hof; J E Repine; G S Giebink; J R Hoidal
Journal:  Am Rev Respir Dis       Date:  1981-08

5.  Phagocytosis and killing of common bacterial pathogens of the lung by human alveolar macrophages.

Authors:  S Jonsson; D M Musher; A Chapman; A Goree; E C Lawrence
Journal:  J Infect Dis       Date:  1985-07       Impact factor: 5.226

6.  Phagocytosis by human alveolar macrophages and neutrophils: qualitative differences in the opsonic requirements for uptake of Staphylococcus aureus and Streptococcus pneumoniae in vitro.

Authors:  D G Hof; J E Repine; P K Peterson; J R Hoidal
Journal:  Am Rev Respir Dis       Date:  1980-01

7.  The critical role of complement in experimental pneumococcal sepsis.

Authors:  S W Hosea; E J Brown; M M Frank
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

Review 8.  The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream.

Authors:  E J Brown; S W Hosea; M M Frank
Journal:  Rev Infect Dis       Date:  1983 Sep-Oct

9.  Phagocytosis, bacterial killing, and metabolism by purified human lung phagocytes.

Authors:  J R Hoidal; D Schmeling; P K Peterson
Journal:  J Infect Dis       Date:  1981-07       Impact factor: 5.226

10.  Toll, a new piece in the puzzle of innate immunity.

Authors:  S D Wright
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

View more
  49 in total

Review 1.  The development and function of lung-resident macrophages and dendritic cells.

Authors:  Manfred Kopf; Christoph Schneider; Samuel P Nobs
Journal:  Nat Immunol       Date:  2015-01       Impact factor: 25.606

Review 2.  Adaptation to Adversity: the Intermingling of Stress Tolerance and Pathogenesis in Enterococci.

Authors:  Anthony O Gaca; José A Lemos
Journal:  Microbiol Mol Biol Rev       Date:  2019-07-17       Impact factor: 11.056

3.  Effect of nonheme iron-containing ferritin Dpr in the stress response and virulence of pneumococci.

Authors:  Chun-Zhen Hua; Angela Howard; Richard Malley; Ying-Jie Lu
Journal:  Infect Immun       Date:  2014-07-07       Impact factor: 3.441

4.  Dynamic changes in Mcl-1 expression regulate macrophage viability or commitment to apoptosis during bacterial clearance.

Authors:  Helen M Marriott; Colin D Bingle; Robert C Read; Karen E Braley; Guido Kroemer; Paul G Hellewell; Ruth W Craig; Moira K B Whyte; David H Dockrell
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

5.  Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease.

Authors:  Charles S Berenson; Ragina L Kruzel; Ellana Eberhardt; Sanjay Sethi
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

Review 6.  Bench-to-bedside review: bacterial pneumonia with influenza - pathogenesis and clinical implications.

Authors:  Koenraad F van der Sluijs; Tom van der Poll; René Lutter; Nicole P Juffermans; Marcus J Schultz
Journal:  Crit Care       Date:  2010-04-19       Impact factor: 9.097

7.  Simple measures are as effective as invasive techniques in the diagnosis of pulmonary tuberculosis in Malawi.

Authors:  D J Bell; R Dacombe; S M Graham; A Hicks; D Cohen; T Chikaonda; N French; M E Molyneux; E E Zijlstra; S B Squire; S B Gordon
Journal:  Int J Tuberc Lung Dis       Date:  2009-01       Impact factor: 2.373

8.  Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses.

Authors:  Stephen B Gordon; Rose Malamba; Neema Mthunthama; Elizabeth R Jarman; Kondwani Jambo; Khuzwayo Jere; Eduard E Zijlstra; Malcolm E Molyneux; John Dennis; Neil French
Journal:  Vaccine       Date:  2008-08-15       Impact factor: 3.641

Review 9.  Potential role for mucosally active vaccines against pneumococcal pneumonia.

Authors:  Kondwani C Jambo; Enoch Sepako; Robert S Heyderman; Stephen B Gordon
Journal:  Trends Microbiol       Date:  2009-12-22       Impact factor: 17.079

10.  The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages.

Authors:  Marc Daigneault; Julie A Preston; Helen M Marriott; Moira K B Whyte; David H Dockrell
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.